Dietrich A. Stephan - Sep 28, 2022 Form 4 Insider Report for NeuBase Therapeutics, Inc. (NBSE)

Role: CEO, Director, 10%+ Owner
Signature: /s/ Dietrich Stephan
Stock symbol: NBSE
Transactions as of: Sep 28, 2022
Transactions value $: $0
Form type: 4
Date filed: 9/30/2022, 07:45 PM
Previous filing: Jan 25, 2022
Next filing: Feb 15, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NBSE	Common Stock	Options Exercise	$825	+750K	+1123.17%	$0.00^*	817K	Sep 28, 2022	Direct	F1
holding	NBSE	Common Stock						1.27M	Sep 28, 2022	See footnote	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NBSE	Stock option (right to buy)	Options Exercise	-$825	-750K	-22.94%	$0.00^*	2.52M	Sep 28, 2022	Common Stock	750K	$0.00	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares held by the reporting person as a tenant by the entirety with his spouse.
F2	These shares are held in an irrevocable trust in which the spouse of the reporting person is the investment trustee, and the spouse and the descendants of the reporting person are its beneficiaries, and another irrevocable trust in which the reporting person is the investment trustee, and the reporting person and the descendants of the reporting person's spouse are its beneficiaries.